
Sign up to save your podcasts
Or


Did you know that estrogen receptor-targeting therapies could help reduce chemotherapy exposure and its associated toxicities in advanced HER2-positive disease? Credit available for this activity expires: 1/29/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002178?ecd=bdc_podcast_libsyn_mscpedu
By Medscape Podcasts4
77 ratings
Did you know that estrogen receptor-targeting therapies could help reduce chemotherapy exposure and its associated toxicities in advanced HER2-positive disease? Credit available for this activity expires: 1/29/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002178?ecd=bdc_podcast_libsyn_mscpedu

322 Listeners

498 Listeners

1,646 Listeners

876 Listeners

14 Listeners

16 Listeners

292 Listeners

3,357 Listeners

8,579 Listeners

191 Listeners

93 Listeners

514 Listeners

368 Listeners

61 Listeners

28 Listeners

425 Listeners

374 Listeners

29,248 Listeners

65 Listeners